Manganese compounds

The first descriptions of manganism appear in the 1837 medical literature, when Scottish physician James Couper reported a severe neurological syndrome in five workers from a manganese ore crushing mill — tremor, rigidity, and loss of balance indistinguishable from Parkinson's disease except in younger workers [1]. The mechanism remained obscure for over a century until dopamine neurotransmission was understood, at which point manganese's selective toxicity to the globus pallidus and striatum was characterized as a result of manganese accumulation interfering with dopamine synthesis and mitochondrial function in these basal ganglia structures [2]. Industrially, manganese is the fourth most produced metal globally — 90% goes into steel production as a deoxidizer and hardener (every piece of steel contains manganese). Other major uses include dry cell batteries (manganese dioxide), agricultural fungicides (maneb, mancozeb), and MMT as a gasoline antiknock additive (though MMT was banned from U.S. gasoline but used in some other countries) [1]. Welding on steel releases manganese-containing fume — manganese is present in welding rods and in the steel being welded [2].

Welders are the largest occupationally exposed group globally — the WHO estimates 11 million welders worldwide with regular manganese fume inhalation [1]. Steel production, ferroalloy smelting, manganese ore mining, and battery manufacturing are other high-exposure industries [2]. Environmental exposure from MMT-containing gasoline combustion deposits manganese in traffic-adjacent soil and air [1]. Infant formula and parenteral nutrition historically contained higher manganese than human breast milk — excess manganese in early life affects neurodevelopment [2]. People drinking water from wells near manganese-rich geological formations (manganese occurs naturally in many groundwater aquifers) may have elevated dietary manganese intake [1].

Manganese accumulates in the basal ganglia — particularly the globus pallidus, striatum, and substantia nigra — where it causes selective toxicity to dopaminergic and GABAergic neurons [1]. The mechanism involves mitochondrial dysfunction (manganese inhibits complex I of the respiratory chain), oxidative stress from manganese-catalyzed free radical generation, and interference with dopamine metabolism [2]. Manganism presents as a progressive extrapyramidal syndrome: initial stages involve psychiatric symptoms (irritability, emotional lability — the 'manganese madness' described in early case reports), followed by progressive motor impairment resembling Parkinson's disease [1]. Unlike Parkinson's, manganism preferentially affects the globus pallidus rather than the substantia nigra, and responds poorly to levodopa therapy [2].

Welders with 10+ years of continuous welding face the highest risk of subclinical manganism [1]. Ferroalloy smelter workers, manganese battery production workers, and ore miners represent other high-risk occupational groups [2]. Infants receiving soy-based formulas or parenteral nutrition may receive excess manganese [1]. People drinking water with manganese above EPA's secondary standard (0.05 mg/L) — common in some New England and Midwestern bedrock aquifers [2].

1. Welders should use local exhaust ventilation (LEV) at the weld point and NIOSH-approved particulate respirators to reduce manganese fume inhalation [1]. 2. Test your well water for manganese — the EPA secondary standard is 50 µg/L; water above 300 µg/L is associated with neurodevelopmental effects in children [2]. 3. For infants, prioritize breast milk over soy formula where possible — manganese in breast milk is 3-10 µg/L versus 50-100 µg/L in soy formula [1]. 4. Participate in biological monitoring programs if working in high-manganese exposure industries [2].